✦ LIBER ✦

Effects of Nonpeptide Vasopressin V2 Antagonist Tolvaptan (OPC-41061) in Rats with Heart Failure

✍ Scribed by Punniyakoti Veeraveedu Thanikachalam; Kenichi Watanabe; Rajarajan Amirthalingam Thandavarayan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of nonpeptide vasopressin V2 ant

✍ Punniyakoti T. Veeraveedu; Kenichi Watanabe; Meilei Ma; Suresh S. Palaniyandi; K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 365 KB

Effects of V2-receptor antagonist tolvap

✍ Punniyakoti T. Veeraveedu; Kenichi Watanabe; Meilei Ma; Suresh S. Palaniyandi; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Effects of long-term oral treatment with

✍ Masayuki Takeuchi; Jong-Dae Lee; Hiromasa Shimizu; Takanori Ueda 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Effects of the Vasopressin V2 Receptor A

✍ James E. Udelson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Effects of tolvaptan, a vasopressin anta

✍ M Gheorghiade; W.A Gattis; C.M O'Connor 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 41 KB

A Case of Severe Chronic Heart Failure S

✍ Yuna Yamagami; Hideyuki Kinoshita; Koichiro Kuwahara; Yoshihiro Kuwabara; Shinji 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 80 KB